Expression of P-Glycoprotein in the Intestinal Epithelium of Dogs with Lymphoplasmacytic Enteritis

Journal of Comparative Pathology

Volumn 145, Issue 2-3, 2011, Pages 199-206

  Van der Heyden, S ^a   Vercauteren, G ^a   Daminet, S ^b   Paepe, D ^b   Chiers, K ^a   Polis, I ^b   Waelbers, T ^b   Hesta, M ^c   Schauvliege, S ^a   Wegge, B ^a   Ducatelle, R ^a  

^a GHENT UNIVERSITY   (Belgium)

^b Department of Medicine and Clinical Biology of Small Animals ^*  (Belgium)

^c Genetics and Ethology   (Belgium)

Author keywords

Dog; Inflammatory bowel disease; Lymphoplasmacytic enteritis; P glycoprotein

Indexed keywords

ANTIBIOTIC AGENT; ANTIPARASITIC AGENT; GLUCOCORTICOID; GLYCOPROTEIN P;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CLINICAL ASSESSMENT; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DUODENUM BIOPSY; ENDOSCOPIC BIOPSY; ENTERITIS; INTESTINE BIOPSY; INTESTINE EPITHELIUM; LYMPHOPLASMACYTIC ENTERITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY;

ANIMALS; BIOPSY; DOG DISEASES; DOGS; DUODENAL DISEASES; ENTERITIS; IMMUNOHISTOCHEMISTRY; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; P-GLYCOPROTEIN;

ANIMALIA; BACTERIA (MICROORGANISMS); CANIS FAMILIARIS;

EID: 79960273079     PISSN: 00219975     EISSN: 15323129     Source Type: Journal    
DOI: 10.1016/j.jcpa.2011.01.003     Document Type: Article

References (34)

1. Allenspach K., Bergman P.J., Sauter S., Gröne A., Doherr M.G., et al. P-glycoprotein expression in lamina propria lymphocytes of duodenal biopsy samples in dogs with chronic idiopatic enteropathies. Journal of Comparative Pathology 2006, 134:1-7.
2. Allenspach K., Steiner J.M., Shah B.N., Berghoff N., Ruaux C., et al. Evaluation of gastrointestinal permeability and mucosal absorptive capacity in dogs with chronic enteropathy. American Journal of Veterinary Research 2006, 67:479-483.
3. Allenspach K., Wieland B., Gröne A., Gaschen F. Chronic enteropathies in dogs: evaluation of risk factors for negative outcome. Journal of Veterinary Internal Medicine 2007, 21:700-708.
4. Altuvia S., Stein W.D., Goldenberg S., Kane S.E., Pastan I., et al. Targeted disruption of the mouse MDR1b gene reveals that steroid hormones enhance MDR1 gene expression. Journal of Biological Chemistry 1993, 268:27127-27132.
5. Banner K.H., Cattaneo C., Le Net J.-L., Popovic A., Collins D., et al. Macroscopic, microscopic and biochemical characterisation of spontaneous colitis in a transgenic mouse, deficient in the multiple drug resistance 1a gene. British Journal of Pharmacology 2004, 143:590-598.
6. Blokzijl H., Vander Borght S., Bok L.I.H., Libbrecht L., Geuken M., et al. Decreased P-glycoprotein (P-gp/MDR1) expression in inflamed human intestinal epithelium is independent of PXR protein levels. Inflammatory Bowel Disease 2007, 13:710-720.
7. Burgener I.A., König A., Allenspach K., Sauter A.N., Boisclair S.N., et al. Upregulation of Toll-like receptors in chronic enteropathies in dogs. Journal of Veterinary Internal Medicine 2008, 22:553-560.
8. Buyse M., Radeva G., Bado A., Farinotti R. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochemical Pharmacology 2005, 69:1745-1754.
9. Casamian-Sorrosal D., Willard M.D., Murray J.K., Hall E.J., Taylor S.S., et al. Comparison of histopathologic findings in biopsies from the duodenum and ileum of dogs with enteropathy. Journal of Veterinary Internal Medicine 2010, 24:80-83.
10. Cordon-Cardo C., O'Brien J.P., Casals D., Rittman-Grauer L., Biedler J.J., et al. Multi-drug-resistance gene (P-gp) is expressed by endothelial cells at blood-brain-barrier sites. Proceedings of the National Academy of Sciences USA 1989, 86:695-698.
11. Dandrieux J.R., Bornand V.F., Doherr M.G., Kano R., Zurbriggen A., et al. Evaluation of lymphocyte apoptosis in dogs with inflammatory bowel disease. American Journal of Veterinary Research 2008, 69:1279-1285.
12. Day M.J., Bilzer T., Mansell J., Wilcock B., Hall E.J., et al. Histopathological standards for the diagnosis of gastrointestinal inflammation in endoscopic biopsy samples from the dog and cat: a report from the World Small Animal Veterinary Association Gastrointestinal Standardization Group. Journal of Comparative Pathology 2008, 138:S1-S43.
13. Fakhoury M., Lecordier J., Medard Y., Peuchmaur M., Jacqz-Aigrain E. Impact of inflammation on the duodenal mRNA expression of CYP3A and P-glycoprotein in children with Crohn's disease. Inflammatory Bowel Disease 2006, 12:745-749.
14. Garcia-Sancho M., Rodrigez-Franco F., Sainz A., Mancho C., Rodriguez A. Evaluation of clinical, macroscopic, and histopathologic response to treatment in nonhypoproteinemic dogs with lympho-plasmacytic enteritis. Journal of Veterinary Internal Medicine 2007, 21:11-17.
15. Georges E., Bradley G., Gariepy J., Ling V. Detection of P-glycoprotein isoforms by gene-specific monoclonal antibodies. Proceedings of the National Academy of Sciences USA 1989, 87:152-156.
16. German A.J., Hall E.J., Day M.J. Chronic intestinal inflammation and intestinal disease in dogs. Journal of Veterinary Internal Medicine 2003, 17:8-20.
17. German A.J., Helps C.R., Hall E.J., Day M.J. Cytokine mRNA expression in mucosal biopsies from German shepherd dogs with small intestinal enteropathies. Digestive Diseases and Sciences 2000, 45:7-17.
18. Ho G.T., Gaya D.R., Satsangi J. Multidrug resistance (MDR1) gene in inflammatory bowel disease: a key playerŽ. Inflammatory Bowel Disease 2005, 11:1013-1019.
19. Jergens A.E., Schreiner C.A., Frank D.E., Niyo Y., Ahrens F.E., et al. A scoring index for disease activity in canine inflammatory bowel disease. Journal of Veterinary Internal Medicine 2003, 17:291-297.
20. Jergens A.E., Sonea I.M., O'Connor A.M., Kauffman L.K., Grozdanic S.D., et al. Intestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal. Comparative Medicine 2009, 59:153-162.
21. Kobayashi S., Ohno K., Uetsuka K., Nakashima K., Setoguchi A., et al. Measurement of intestinal mucosal permeability in dogs with lymphocytic-plasmacytic enteritis. Journal of Veterinary Medicine and Sciences 2007, 69:745-749.
22. Lin J.H., Chiba M., Chen I.W., Nishime J.A., deLuna F.A., et al. Effect of dexamethasone on the intestinal first pass mechanism of indinavir in rats: evidence of cytochrome P450 A and P-glycoprotein induction. Drug Metabolism and Disposition 1999, 27:1187-1193.
23. Lin J.H., Yamazaki M. Role of P-glycoprotein in pharmacokinetics. Clinical Pharmacokinetics 2003, 42:59-98.
24. Lizasa H., Genda N., Kitano T., Tomita M., Nishihara K., et al. Altered expression and function of P-glycoprotein in dextran sodium sulfate-induced colitis in mice. Journal of Pharmaceutical Sciences 2003, 92:569-576.
25. Locher C., Tipold A., Welle M., Busato A., Zurbriggen A., et al. Quantitative assessment of mast cells and expression of IgE protein and mRNA for IgE and interleukin 4 in the gastrointestinal tract of healthy dogs and dogs with inflammatory bowel disease. American Journal of Veterinary Research 2001, 62:211-216.
26. Luckschander N., Hall J.A., Gaschen F., Forster U., Wenzlow N., et al. Activation of nuclear factor-kappa B in dogs with chronic enteropathies. Veterinary Immunology and Immunopathology 2010, 133:228-236.
27. Münster M., Hörauf A., Bilzer T. Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with inflammatory bowel disease. Berliner und Munchener Tierarztliche Wochenschrift 2006, 119:493-505.
28. Panwala C.M., Jones J.C., Viney J.L. A novel model of inflammatory bowel disease: mice deficient for the multiple drug resistance gene, MDR1a, spontaneously develop colitis. Journal of Immunology 1998, 161:5733-5744.
29. Peters I.R., Helps C.R., Calvert E.L., Hall E.J., Day M.J. Cytokine mRNA quantification in duodenal mucosa from dogs with chronic enteropathies by real-time reverse transcriptase polymerase chain reaction. Journal of Veterinary Internal Medicine 2005, 19:644-653.
30. Schwab M., Schaeffeler E., Marx C., Fromm M.F., Kaskas B., et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology 2003, 124:26-33.
31. Sorensen S.H., Proud F.J., Rutgers H.C., Markwell P., Adam A., et al. A blood test for intestinal permeability and function: a new tool for the diagnosis of chronic intestinal disease in dogs. Clinica Chimica Acta 1997, 264:103-115.
32. Thiebaut F., Tsuruo T., Hamada H., Gottesman M.M., Pastan I., et al. Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proceedings of the National Academy of Sciences USA 1987, 84:7735-7738.
33. Washabau R.J., Day M.J., Willard M.D., Hall E.J., Jergens A.E., et al. Endoscopic, biopsy and histopathologic guidelines for the evaluation of gastrointestinal inflammation in companion animals. Journal of Veterinary Internal Medicine 2010, 24:10-26.
34. Xenoulis P.G., Palculict B., Allenspach K., Steiner J.M., Van House A.M., et al. Molecular-phylogenetic characterization of microbial communities imbalances in the small intestine of dogs with inflammatory bowel disease. FEMS Microbiology and Ecology 2008, 66:579-589.